Tekla Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$2.63M | – | 225 |
|
|
2020
Q4 | $2.63M | Hold |
20,000
| – | – | 0.09% | 148 |
|
|
2020
Q3 | $1.01M | Hold |
20,000
| – | – | 0.04% | 179 |
|
|
2020
Q2 | $953K | Hold |
20,000
| – | – | 0.04% | 194 |
|
|
2020
Q1 | $980K | Hold |
20,000
| – | – | 0.04% | 177 |
|
|
2019
Q4 | $1.15M | Buy |
+20,000
| New | +$1.15M | 0.04% | 179 |
|
|
2019
Q1 | – | Sell |
-27,900
| Closed | -$384K | – | 204 |
|
|
2018
Q4 | $384K | Hold |
27,900
| – | – | 0.02% | 192 |
|
|
2018
Q3 | $278K | Buy |
+27,900
| New | +$278K | 0.01% | 204 |
|